These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium. Ma X; Takahashi Y; Wu W; Liang W; Chen J; Chakraborty D; Li Y; Du Y; Benyajati S; Ma JX J Biol Chem; 2021 Oct; 297(4):101185. PubMed ID: 34509473 [TBL] [Abstract][Full Text] [Related]
50. Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17. Yang G; Cui M; Jiang W; Sheng J; Yang Y; Zhang X Aging (Albany NY); 2021 Jun; 13(12):16859-16872. PubMed ID: 34182543 [TBL] [Abstract][Full Text] [Related]
51. The importance of a disintegrin and metalloproteinase (ADAM)10 and ADAM17 in the pathogenesis of psoriasis. Gül C; Kilic S; Şehitoğlu MH Clin Exp Dermatol; 2022 Sep; 47(9):1673-1678. PubMed ID: 35474465 [TBL] [Abstract][Full Text] [Related]
52. Tumor-derived exosomal ADAM17 promotes pre-metastatic niche formation by enhancing vascular permeability in colorectal cancer. Li K; Xue W; Lu Z; Wang S; Zheng J; Lu K; Li M; Zong Y; Xu F; Dai J; Yang Y; Sun J J Exp Clin Cancer Res; 2024 Feb; 43(1):59. PubMed ID: 38413999 [TBL] [Abstract][Full Text] [Related]
53. The role of S100B/RAGE-enhanced ADAM17 activation in endothelial glycocalyx shedding after traumatic brain injury. Zou Z; Li L; Li Q; Zhao P; Zhang K; Liu C; Cai D; Maegele M; Gu Z; Huang Q J Neuroinflammation; 2022 Feb; 19(1):46. PubMed ID: 35148784 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Wei Y; Nazari-Jahantigh M; Neth P; Weber C; Schober A Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):449-54. PubMed ID: 23324496 [TBL] [Abstract][Full Text] [Related]
55. Immunomodulatory role of metalloproteinase ADAM17 in tumor development. Wang K; Xuan Z; Liu X; Zheng M; Yang C; Wang H Front Immunol; 2022; 13():1059376. PubMed ID: 36466812 [TBL] [Abstract][Full Text] [Related]
56. Neopterin Counters Vascular Inflammation and Atherosclerosis. Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219 [TBL] [Abstract][Full Text] [Related]
57. Short-term TNFα shedding is independent of cytoplasmic phosphorylation or furin cleavage of ADAM17. Schwarz J; Broder C; Helmstetter A; Schmidt S; Yan I; Müller M; Schmidt-Arras D; Becker-Pauly C; Koch-Nolte F; Mittrücker HW; Rabe B; Rose-John S; Chalaris A Biochim Biophys Acta; 2013 Dec; 1833(12):3355-3367. PubMed ID: 24135057 [TBL] [Abstract][Full Text] [Related]
58. ADAM17 and EGFR regulate IL-6 receptor and amphiregulin mRNA expression and release in cigarette smoke-exposed primary bronchial epithelial cells from patients with chronic obstructive pulmonary disease (COPD). Stolarczyk M; Amatngalim GD; Yu X; Veltman M; Hiemstra PS; Scholte BJ Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27561911 [TBL] [Abstract][Full Text] [Related]
59. Identification of Molecular Determinants in iRhoms1 and 2 That Contribute to the Substrate Selectivity of Stimulated ADAM17. Zhao Y; Dávila EM; Li X; Tang B; Rabinowitsch AI; Perez-Aguilar JM; Blobel CP Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361585 [TBL] [Abstract][Full Text] [Related]
60. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17. Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]